Abdominal Aortitis after Use of Granulocyte Colony-Stimulating Factor

被引:0
|
作者
Giridhar U. Adiga
Dahlia Elkadi
Sandeep K. Malik
Jill D. Fitzpatrick
Stefan Madajewicz
机构
[1] New York Medical College,Department of Oncology, Montefiore Medical Center North Division
[2] Emory University School of Medicine,Department of Hematology and Medical Oncology
[3] Stony Brook University Cancer Center,Emeritus of Medicine
来源
关键词
Abdominal Aortic Aneurysm; Aortic Wall; Pantoprazole; Giant Cell Arteritis; African American Male;
D O I
暂无
中图分类号
学科分类号
摘要
Granulocyte colony-stimulating factor (G-CSF) is a recombinant human glycoprotein that promotes proliferation and differentiation of granulocytic-committed progenitors. It is commonly used to treat neutropenia and is generally well tolerated. Occurrences of rare but serious adverse events in association with the use of G-CSF have been described. We report the case of a 54-year-old male with squamous cell carcinoma of the lung who developed abdominal aortitis following the use of G-CSF. Other possible aetiological conditions were excluded based on laboratory and radiological evaluations. To our knowledge, this represents the second case report demonstrating an association between aortitis and the use of G-CSF.
引用
收藏
页码:821 / 825
页数:4
相关论文
共 50 条
  • [31] The use of granulocyte colony-stimulating factor for treatment of autoimmune neutropenia
    Smith, MA
    Smith, JG
    CURRENT OPINION IN HEMATOLOGY, 2001, 8 (03) : 165 - 169
  • [32] An audit of the use of granulocyte colony-stimulating factor in septic shock
    Stephens, DP
    Fisher, DA
    Currie, BJ
    INTERNAL MEDICINE JOURNAL, 2002, 32 (04) : 143 - 148
  • [33] Aortitis which developed after the administration of granulocyte-colony stimulating factor
    Mukai, Tomoyuki
    Kubo, Shinichiro
    Morita, Yoshitaka
    Yamamoto, Mari
    Ikeda, Masahiko
    MODERN RHEUMATOLOGY CASE REPORTS, 2020, 4 (01) : 74 - 78
  • [34] Granulocyte colony-stimulating factor serum and urine concentrations in neutropenic neonates before and after intravenous administration of recombinant granulocyte colony-stimulating factor
    Calhoun, DA
    Lunoe, M
    Du, Y
    Hutson, AD
    Veerman, M
    Christensen, RD
    PEDIATRICS, 2000, 105 (02) : 392 - 397
  • [35] Granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor and macrophage colony-stimulating factor in the treatment of acute myeloid leukemia and acute lymphoblastic leukemia
    Ohno, R
    LEUKEMIA RESEARCH, 1998, 22 (12) : 1143 - 1154
  • [37] Granulocyte colony-stimulating factor-associated aortitis in a woman with breast cancer: a case report
    Nana Matsumoto
    Naoto Kondo
    Yumi Wanifuchi-Endo
    Tomoko Asano
    Tomoka Hisada
    Yasuaki Uemoto
    Akiko Kato
    Mitsuo Terada
    Natsumi Yamanaka
    Ayaka Isogai
    Muneyuki Takayama
    Takeshi Hasegawa
    Koichi Ito
    Keiji Mashita
    Tatsuya Toyama
    Surgical Case Reports, 8
  • [38] Mature and immature myeloid cells decrease the granulocyte colony-stimulating factor level by absorption of granulocyte colony-stimulating factor
    Saito, K
    Nakamura, Y
    Waga, K
    Hirota, K
    Inoue, F
    Enokihara, H
    Nara, N
    Furusawa, S
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 1998, 67 (02) : 145 - 151
  • [39] Granulocyte colony-stimulating factor-associated aortitis in a woman with breast cancer: a case report
    Matsumoto, Nana
    Kondo, Naoto
    Wanifuchi-Endo, Yumi
    Asano, Tomoko
    Hisada, Tomoka
    Uemoto, Yasuaki
    Kato, Akiko
    Terada, Mitsuo
    Yamanaka, Natsumi
    Isogai, Ayaka
    Takayama, Muneyuki
    Hasegawa, Takeshi
    Ito, Koichi
    Mashita, Keiji
    Toyama, Tatsuya
    SURGICAL CASE REPORTS, 2022, 8 (01)
  • [40] Isolated abdominal aortitis following administration of granulocyte colony stimulating factor (G-CSF)
    Edward B. Miller
    Roy Grosu
    Zvi Landau
    Clinical Rheumatology, 2016, 35 : 1655 - 1657